Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa.

Vibha SinghalAmita BoseMeghan SlatteryMelanie S HainesMark A GoldsteinNupur GuptaKathryn S BrighamSeda EbrahimiKristin N JavarasMary L BouxseinKamryn T EddyKaren K MillerDavid SchoenfeldAnne KlibanskiMadhusmita Misra

Published in: The Journal of clinical endocrinology and metabolism (2021)

We found no additive benefit of rhIGF-1 administration for 12 months over transdermal estrogen replacement alone in this cohort of young women with AN.

Keyphrases

anorexia nervosa
estrogen receptor
bone mineral density
soft tissue
bone loss
growth hormone